Business News • PR NewsWire • Promising Pre-clinical Data Supporting BerGenBio's Pipeline to be Published and Presented at Upcoming Leading Conferences

Promising Pre-clinical Data Supporting BerGenBio's Pipeline to be Published and Presented at Upcoming Leading Conferences

Promising Pre-clinical Data Supporting BerGenBio's Pipeline to be Published and Presented at Upcoming Leading Conferences

BERGEN, Norway, 13 April, 2018 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO) announces that promising pre-clinical data demonstrating that selective AXL inhibition counteracts the progression of aggressive fibrosis in the lung and liver has been published in the international...

View More : https://www.prnewswire.com/news-releases/promising-pre-clinical-data-supporting-bergenbios-pipeline-to-be-published-and-...

Releted News by prnewswire

Checkout.com Appoints Remo Giovanni Abbondandolo as VP of Business Development MENA

Straumann devient investisseur stratégique de Dental Monitoring

Zhaopin Leverages AI and Big Data to Reshape China Talent Recruitment Sector

Invitation to Electrolux Q1 Presentation